Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions.
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT03721614
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Registry
-
NCT03721614
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT03721614. Randomized; no masking; primary purpose treatment. Start 2019-09-15 (anticipated); primary completion 2021-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions.
- Acronym
- Morph RCT-1
- Condition
- Coronary Artery Disease
- Intervention (Device)
- BioMime™ Morph - Sirolimus Eluting Coronary Stent System
- Intervention (Device)
- Xience family Everolimus Coronary Stent Systems
- Lead sponsor
- Meril Life Sciences Pvt. Ltd.
Record details
- Record id
cardio:ct-nct03721614- Content hash
a1cc186eab21c29dbf27dd592e6df5a4fb426d518d7c22837f5c2a731a48ae61